European journal of medical research · 2025
Transnasal humidified rapid insufflation ventilatory exchange versus conventional facemask breathing for preoxygenation during anesthesia induction in TBI surgery: a randomized controlled trial.
СтатьяРандомизированное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Chen Xiaoping, Yang Chen, Zhao Yue, Gao Ju, Ge Yali, Zhang Yang
Аннотация
OBJECTIVE: To assess the effect of transnasal humidified rapid insufflation ventilatory exchange (THRIVE) on regional cerebral oxygen saturation (rScO2) during general anesthesia induction in traumatic brain injury (TBI) emergency surgery.
METHODS: In this prospective randomized trial, 63 TBI patients undergoing emergency intracranial hematoma removal were allocated to conventional mask ventilation group (n = 32; 8 L/min O2, FiO2 1.00) or THRIVE group (n = 31; 30-50 L/min O2, FiO2 1.00). Outcomes included rScO2, PaO2, PaCO2, hypoxemia incidence (SpO2 < 95%), end-tidal CO2 (PETCO2), and Glasgow Outcome Scale (GOS) at discharge.
RESULTS: After 10-min preoxygenation, the THRIVE group exhibited higher rScO2 (surgical side: 70.9% ± 3.6% vs. 63.6% ± 2.8%; non-surgical: 79.1% ± 1.6% vs. 71.2% ± 2.7%; P < 0.01), increased PaO2 (450.23 ± 60.99 vs. 264.88 ± 49.33 mmHg), and reduced PaCO2 (37.81 ± 3.65 vs. 43.59 ± 3.76 mmHg; P < 0.01). During tracheal intubation, hypoxemia events, defined as SpO2 < 95%, occurred in 0/31 patients (0%) in the THRIVE group versus 9/32 patients (28.1%) in the conventional ventilation group (P < 0.01). PETCO2 post-intubation was lower in the THRIVE group (43.10 ± 2.66 vs. 49.22 ± 3.31 mmHg; P < 0.01). Patients receiving THRIVE had a higher proportion of good neurological outcomes (GOS > 3: 35.5% vs. P < 0.05). ICU/hospital stay and gastric antrum cross-sectional area showed no intergroup differences.
CONCLUSION: THRIVE could significantly increase rScO2 during anesthesia induction in TBI emergency surgery patients and improve their neurological functional prognosis. Trial registration retrospectively registered; Chinese Clinical Trial Registry, www.chictr.org.cn, number ChiCTR 2300073951: Registered on June 26.2023.
METHODS: In this prospective randomized trial, 63 TBI patients undergoing emergency intracranial hematoma removal were allocated to conventional mask ventilation group (n = 32; 8 L/min O2, FiO2 1.00) or THRIVE group (n = 31; 30-50 L/min O2, FiO2 1.00). Outcomes included rScO2, PaO2, PaCO2, hypoxemia incidence (SpO2 < 95%), end-tidal CO2 (PETCO2), and Glasgow Outcome Scale (GOS) at discharge.
RESULTS: After 10-min preoxygenation, the THRIVE group exhibited higher rScO2 (surgical side: 70.9% ± 3.6% vs. 63.6% ± 2.8%; non-surgical: 79.1% ± 1.6% vs. 71.2% ± 2.7%; P < 0.01), increased PaO2 (450.23 ± 60.99 vs. 264.88 ± 49.33 mmHg), and reduced PaCO2 (37.81 ± 3.65 vs. 43.59 ± 3.76 mmHg; P < 0.01). During tracheal intubation, hypoxemia events, defined as SpO2 < 95%, occurred in 0/31 patients (0%) in the THRIVE group versus 9/32 patients (28.1%) in the conventional ventilation group (P < 0.01). PETCO2 post-intubation was lower in the THRIVE group (43.10 ± 2.66 vs. 49.22 ± 3.31 mmHg; P < 0.01). Patients receiving THRIVE had a higher proportion of good neurological outcomes (GOS > 3: 35.5% vs. P < 0.05). ICU/hospital stay and gastric antrum cross-sectional area showed no intergroup differences.
CONCLUSION: THRIVE could significantly increase rScO2 during anesthesia induction in TBI emergency surgery patients and improve their neurological functional prognosis. Trial registration retrospectively registered; Chinese Clinical Trial Registry, www.chictr.org.cn, number ChiCTR 2300073951: Registered on June 26.2023.